Trials / Completed
CompletedNCT00004480
Study of Botulinum Toxin in Patients With Primary Hyperhidrosis
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- —
- Sponsor
- Icahn School of Medicine at Mount Sinai · Academic / Other
- Sex
- All
- Age
- 16 Years
- Healthy volunteers
- Not accepted
Summary
OBJECTIVES: I. Determine the optimal dose of botulinum toxin necessary to decrease sweating in patients with primary hyperhidrosis.
Detailed description
PROTOCOL OUTLINE: Patients receive injections of botulinum toxin in the clinical trial for 6 months. Patients undergo an iodine starch test and a sympathetic skin response test to assess the efficacy of the drug. Patients also complete questionnaires to evaluate the amount of sweating.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | botulinum toxin type A |
Timeline
- Start date
- 1999-07-01
- First posted
- 1999-10-19
- Last updated
- 2005-06-24
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00004480. Inclusion in this directory is not an endorsement.